Navigation Links
China Sky One Medical, Inc. to Conduct Non-Deal Roadshow in Hong Kong and Singapore
Date:7/28/2009

HARBIN, China, July 28 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company is scheduled to launch a non-deal roadshow ("NDR") in Hong Kong and Singapore in early August, 2009.

China Sky One Medical's Chief Executive Officer, Mr. Yan-qing Liu, and Chief Financial Officer, Mr. Stanley Hao will participate in the NDR to meet with institutional investors and equity analysts from August 4 to August 5 in Hong Kong and on August 6 in Singapore.

"This NDR represents our commitment to maintain communication with investors and better understand their expectations," said Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical. "We will continue this effort by pursuing best practices investor relations activities as we work to build lasting value to our shareholders."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the sta
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Lawyers from The Healy Law Firm s... Illinois on behalf of man rendered an incomplete ...IL (Lexis Nexis) November 30, 2009 -- A Cook Count...r of an Irish immigrant carpenter, 22 years old at...endered an incomplete quadriplegic. The verdict, ...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Three decades ...were being swallowed by children, prompting a swit... presented today at the annual meeting of the Radi...t the new tabs are still potentially unsafe. ,,... beverage can construction in the U.S. was to elim...
(Date:11/30/2009)... Middle-aged men and women who engage in high lev...g damage to their knees and increasing their risk ... today at the annual meeting of the Radiological S...est that people with higher physical activity leve...rmalities and, thus, at higher risk for developing...
(Date:11/30/2009)...S Nov. 30, 2009 UT Southwestern Medical Center r...p families stave off complications associated with... December issue of Pediatrics, suggest that inte...ic children who have received specialized topical ...attacks, emergency room visits and missed adult wo...
(Date:11/29/2009)... The Academy of General Dentistry ...ounty CA, received the Mastership Award during the...D members, commitment to excellence in dental educ...,100 hours of approved continuing dental education... hours dedicated to hands-on skills and techniques...
Breaking Medicine News(10 mins):Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 2Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 3Health News:Beverage Can Stay-Tabs Pose Swallowing Risk 2Health News:Too much physical activity may lead to arthritis 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2
...in automated,medication management, today unveiled...t remote dispensing system designed exclusively fo...eir care. , The company made the announcemen...stem are operating in Texas, and each,InSite unit ...
...tional, Inc. (Amex: BUF ), announced today the C...scuss current business conditions on Tuesday,Novem... number is,(866) 901-2585. The international call ... ctrego@minrad.com , (716) 85...
...e for anti-aging drug trials, study says , ...biomarkers that are highly accurate in determining...hers at California,s Buck Institute for Age Resear... changes in gene expression, and complex computer ...
...., the makers of,Carmex(R) lip balms, today unveil... association with the new site,s launch, the compa...rmex.com. , "We know that Carmex users are s...flects this lifestyle and enables our,customers to...
...ce advertising,agency, recently received two prest...dia (MM&M), a leading healthcare publication. ... and effectiveness in healthcare marketing. Mango...m/cgi-bin/prnh/20081119/AQW573 ) , (Logo: ...
... Larry King,turns 75. In conjunction with his birt...alth Solutions and the LAC+USC Camino de Salud Net...ala in Los Angeles. The,Foundation, which provides...to quintuple-bypass surgery. He decided then, he w...
Other Medicine News:Health News:Talyst Unveils InSite for Long-Term Care 2Health News:Talyst Unveils InSite for Long-Term Care 3Health News:Researchers ID Suite of Genes in Aging Process 2Health News:Carma Laboratories Launches New Carmex(R) Web Site; Unveils Top 10 Reasons for a Virtual Visit 2Health News:Mangos Wins Two Gold Awards 2Health News:The King of Hearts Helps Others Follow a Healthy Road 2Health News:The King of Hearts Helps Others Follow a Healthy Road 3Health News:The King of Hearts Helps Others Follow a Healthy Road 4
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Med...shed ultrasound solutions, will showcase leading u...p, GE Logiq I and Siemens X300 Premium Edition dur...ety of North America (RSNA) conference, being held...sin-based MedPro Imaging markets ultrasound produc...
(Date:11/30/2009)..., , WAYNE, N.J. and CHICAGO, Nov. 30 /PRN...and Annual Meeting of the Radiological Society o...ticals Inc. announced the enrollment of the first ...al to evaluate the efficacy and safety of florbeta...beta-Amyloid plaques in the brain, which are a pat...
(Date:11/30/2009)..., , INDIANAPOLIS, Nov. 30 /PRNews...ration (FDA) has approved Cymbalta® (duloxeti...ed anxiety disorder (GAD) in adults, Eli Lilly and...nce generalized anxiety disorder can be a chronic ...tients find a treatment option that is effective i...
Breaking Medicine Technology:MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 1Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 2Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 3Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 4Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 1Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 2Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 3Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 4Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 1Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 2Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 3Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 4
...gnificant Improvements With ROX-828 In Migraine Pa...s Vs. Placebo, MENLO PARK, Calif., April 28 ROXR...ata from a clinical study of the company,s,novel i...atment of migraine,and related symptoms., The pla...he efficacy,and safety of ROX-828, an intranasal f...
... IIa Efficacy Results, LAUSANNE, Switzerland, Apr...ependent biopharmaceutical development specialist,...ly oncology, presented,positive efficacy results o...clophilin (Cyp) inhibitor with a potent in-vitro a...icates that Debio 025 shows an,important additive ...
Other Medicine Technology:ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 2ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 3Clinical Update - Debio 025 in Hepatitis C 2Clinical Update - Debio 025 in Hepatitis C 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: